Shopping Cart
Cytek Biosciences is actively monitoring and adapting to COVID-19 guidance. Read more about Cytek's support efforts here.
clear

Request a Demo or a Quote

Your contact information:
Product Information:

Why is Immuno-Oncology Important?

Scientists devoted to immuno-oncology (IO) are establishing new ways to target and destroy cancer cells through personalized immunotherapies. Thanks to decades of research and advances in technologies, scientists and healthcare professionals have richly documented the human adaptive and innate immune response mechanisms and are now using that information to design and administer personalized immunotherapies.

These therapies may inhibit or enhance different aspects of the immune response, depending on the action needed to hinder and destroy the life-threatening cancer cells within the human host.

Cytek Solutions Enable the World’s Most Cutting Edge Immuno-Oncology Research.

Explore the case study below to see how.
CASE STUDY

Cancer Vaccine Research at Amsterdam University Medical Center

At the Amsterdam University Medical Center, researchers are using liposomes to target antigen-presenting cells critical for cancer vaccine efficacy. Cancer vaccines help cancer patients positively respond to checkpoint inhibitors by re-invigorating the immune system’s T cell response.

Cancer vaccine effectiveness can be suboptimal, so this group is looking to augment vaccine potency by specifically targeting cells of interest with liposomes. Subsequent studies on both dosing and route of vaccine administration pave the way for more effective cancer vaccines. See how the Cytek Aurora helped this team throughout their research by reading their publication.

Creating New Cancer Vaccine Delivery Vehicles

Quantification of antigen-presenting cells and T cells by the Cytek Aurora in steps 2, 3, and 5 in this research group’s experimental workflow helps the team develop and optimize their cancer vaccine delivery protocol.
ARTICLE

Full Spectrum Flow Cytometry: Powerful Technology for Cancer Immunotherapy Research

Read this Review Article in Frontiers in Molecular Biosciences to learn more.